DePuy Hip Replacement Loosening

Patients Experiencing Problems with a DePuy Hip Replacement May Have Legal Recourse

Our unsafe medical device lawyers are investigating claims involving defects in DePuy Hip replacement medical products. These claims center around premature loosening of these hip implants.

DePuy Orthopaedics, Inc., a Johnson & Johnson company, has recalled two of its hip implant products. The recall follows more than two years of complaints to the Food and Drug Administration. As a result of these premature product failures, many patients underwent a second hip replacement surgery called a “revision surgery”. These revision surgeries sometimes result in unnecessary pain and complications, including infection.

We are also investigating claims related to DePuy hip replacements causing Metallosis, a form of metal poisoning.

The recalled products include the ASR XL Acetabular System, a hip socket used in traditional hip replacement and the ASR Hip Resurfacing System, a partial hip replacement that involves placing a metal cap on the ball of the femur.

More than 90,000 of these devices have been implanted worldwide. DePuy holds itself out as a leading global provider of orthopaedic devices for hip, knee, extremities and trauma, as well as bone cement and operating room products.

If you or a loved one has been harmed by a unsafe medical device, contact us for a free consultation.

Clark Perdue has extensive experience handling claims involving defective medical devices. If you have suffered injury or pain as a result of a DePuy hip replacement, and you would like more information, contact the Ohio Depuy Hip replacement attorneys at Clark, Perdue & List.


Stryker LFIT V40 Femoral Head Recall

On May 22, 2018, Stryker Orthopedics updated its Stryker LFIT V40 Femoral Head Recall to include eight (8) additional catalog numbers.  The original recall occurred in August 2016 and included ...
Read More

Stryker hip implant settlement announced

A national settlement of Stryker hip replacment claims was announced yesterday. The total estimated settlement for the defective hip implants may exceed $1 billion.The settlement provides for the largest base ...
Read More

Stryker Defective Hip Replacements Bellwether Trials Set

The first bellwether trials in the Stryker defective hip replacements litigation have been scheduled. Two trials have been scheduled for June 15, 2015 and July 13, 2015 in the Superior ...
Read More

Defective Hip Replacements: Biomet Agrees to Settlements

Indiana-based Biomet, Inc. has agreed to settle hundreds of lawsuits over its defective hip replacements, the M2A Magnum. The law suits claim that the hip implants needed to be replaced ...
Read More

Defective Hip Replacements: Stryker Agrees to Settle Suits

According to the Long Island News, Stryker has agreed to settle four New Jersey law suits related to defective hip replacements. The lawsuits involved the Stryker ABG II and Rejuvenate ...
Read More

Defective Hip Replacements: Stryker and Biomet Suits Continue

Defective Hip Replacements: Stryker and Biomet Suits Continue Clark, Perdue & List continues to investigate claims for defective hip replacements involving Stryker Rejuvenate and Biomet Magnum hip implants. It is ...
Read More

Jury Awards $8.3M in Defective Hip Replacement Trial

In the first of nearly 11,000 DePuy defective hip replacement lawsuits to go to trial, a California jury found that Johnson & Johnson's DePuy division defectively designed its ASR hip ...
Read More

Johnson & Johnson recalls knee replacement device

A February recall of a major medical device manufactured by Johnson & Johnson could affect scores of Ohio residents. The orthopedic device was subject to a Class I recall, which ...
Read More

Another J&J defective hip replacement recalled

Johnson & Johnson has alerted doctors in 21 countries to stop using their Adept hip implant, as the defective hip replacement has a higher than average failure rate.A British database ...
Read More

First DePuy defective hip replacement trial underway

The first DePuy hip implant trial is underway in Los Angeles. In the case of Kransky v. DePuy, testimony has emerged that the DePuy ASR hip replacement system failed to ...
Read More

FDA addresses defective medical devices

The U.S. Food and Drug Administration (FDA) proposed regulations restricting the sale of all-metal hip implants. Approximately 500,000 Americans have received these defective medical devices, many of which have failed ...
Read More

Johnson & Johnson settles number of hip implant claims

According to Bloomberg News, Johnson & Johnson has agreed to settle the first three DePuy ASR defective hip replacement lawsuits for a sum of $600,000. Bloomberg reports that each of ...
Read More

Stryker Orthopedics recalls hip implants

On July 6, 2012, Stryker Orthopedics announced that it was voluntarily recalling certain hip implant medical devices. According to the company's website, the recalled products are the Rejuvenate Modular and ...
Read More

FDA investigating hip replacement medical device safety

The Food and Drug Administration (FDA) held a two-day meeting beginning on Wednesday, June 27th to study the safety of metal-on-metal hip replacement medical devices. The investigation was prompted by ...
Read More

FDA to discuss defective hip replacements

In response to increasing reports of failure and adverse events, and concern over defective hip replacements, the U.S. Food and Drug Administration ("FDA") announced that it will hold a two-day ...
Read More

Concerns mount over defective hip replacements

Recent studies have confirmed high rates of metal-on-metal hip replacement failures. In February 2011, the Food and Drug Administration issued a public health communication about these defective hip replacements. Instead ...
Read More